One of the main objectives of CTTC is to promote the technological innovation. After more than 10 years of Research and Development (R&D) activities, this objective has been achieved by starting an IPR (Intellectual Property Right) Portfolio based on Testbed and product trade marks and patent applications. In particular, CTTC has registered eleven trade marks and has submitted 24 family patents to national and international offices.

As for the Trade Marks, CTTC registered the following: ADRENALINE Testbed®, EXTREME Testbed®, GEDOMIS®, DEMOCLES ®, ULAND ®, GEMMA ®, GESTALT ® and the product Trade Mark GNSS SDR®. A more detailed description of these testbeds can be found in the section related to Testbeds.

 

 

 

 

 

In addition, during the year 2016, the Trade Mark IOTWORLD®  and Castle Platform ® have been registered and awarded.

 

With respect to the patents, CTTC has submitted 24 family Patents: 21 of them internationally published and 16 of them already awarded (Europe, United States, Japan, HK, China).

 

 

 

­